Discover 483 paid clinical trials in Warwick, Rhode Island. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 483
Collaborative Care Model for Perinatal Wellness Support Services - Population-Level Equity-Centered Systems Change
for
Perinatal Mental Health
Location: Providence RI
Sponsor: Women and Infants Hospital of Rhode Island
Sex: Female
Age: 18+
Code: NCT06849869
Recruiting
The Effect of Intrawound Vancomycin Powder on Surgical Site Infection in Inguinal Lymph Node Dissection
for
Postoperative Complications
Location: Providence RI
Sponsor: Women and Infants Hospital of Rhode Island
Sex: Female
Age: 18+
Code: NCT05625373
Phase2, Phase3, Recruiting
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
Bringing Medicines for HIV Prevention to a Family Planning Clinic
for
HIV, PrEP
Location: Providence RI
Sponsor: Women and Infants Hospital of Rhode Island
Sex: All
Age: 16+
Code: NCT06930508
Recruiting
Rhode Island Community-based Maternal Support Services
for
Perinatal Outcomes, Social Determinants of Health (SDOH),
Location: Providence RI
Sponsor: Women and Infants Hospital of Rhode Island
Sex: Female
Age: 0+
Code: NCT07446374
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
for
Ovarian Neoplasms, Ovarian Cancer
Location: Providence RI, Albany NY, Scarborough ME, New York NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT07318558
Phase3, Recruiting
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
for
Cervical Cancer
Location: Providence RI, New York NY, Willow Grove PA,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT07216703
Phase3, Recruiting
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
E-Mindfulness Approaches for Living After Breast Cancer
for
Breast Cancer, Depression
Location: Providence RI, Boston MA, Burlington MA, Stoneham MA,
Sponsor: NRG Oncology
Sex: All
Age: 18 - 50
Code: NCT06748222
Phase3, Recruiting
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
for
Endometrial Cancer
Location: Providence RI, Boston MA, New Haven CT, Mineola NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT06952504
Phase3, Recruiting
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
for
Advanced Malignant Solid Neoplasm,
Location: Providence RI, Boston MA, Stoneham MA, Springfield MA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0+
Code: NCT05564377
Phase2, Recruiting
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
for
Advanced Solid Tumor, High Grade Serous Adenocarcinoma of Ovary,
Location: Providence RI, New Haven CT, New York NY, Baltimore MD,
Sponsor: Volastra Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05902988
Phase1, Phase2, Recruiting
Study of Lunresertib Alone or in Combination With RP-3500 or Debio 0123 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Providence RI, Boston MA, New Haven CT,
Sponsor: Debiopharm International SA
Sex: All
Age: 12+
Code: NCT04855656
Phase1, Recruiting
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
for
Ovarian Carcinoma
Location: Providence RI, Waterford CT, Boston MA, Hartford CT,